Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer

Cancer Epidemiology

Volumn 39, Issue 5, 2015, Pages 763-768

  Li, Ning ^a   Xu, Miao ^a   Cai, Mu Yan ^a   Zhou, Feng ^a   Li, Chao Feng ^a   Wang, Bao Xiao ^a   Ou, Wei ^a   Wang, Si Yu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Bilirubin; Lung cancer; Prognosis; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BILIRUBIN; BILIRUBIN GLUCURONIDE;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; LOBECTOMY; LOCAL RECURRENCE FREE SURVIVAL; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; AGED; BLOOD; LUNG TUMOR; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; BILIRUBIN; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84941740239     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.06.007     Document Type: Article

References (25)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. D'Addario G., Fruh M., Reck M., Baumann P., Klepetko W., Felip E. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2010, 21(Suppl. 5):v116-9.
3. Crino L., Weder W., van Meerbeeck J., Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2010, 21(Suppl. 5):v103-15.
4. Ostrow J.D., Jandl J.H., Schmid R. The formation of bilirubin from hemoglobin in vivo. J. Clin. Invest. 1962, 41:1628-1637.
5. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235:1043-1046.
6. Horsfall L.J., Rait G., Walters K., Swallow D.M., Pereira S.P., Nazareth I., et al. Serum bilirubin and risk of respiratory disease and death. JAMA 2011, 305:691-697.
7. Wen C.P., Zhang F., Liang D., Wen C., Gu J., Skinner H., et al. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin. Cancer Res. 2014.
8. Ching S., Ingram D., Hahnel R., Beilby J., Rossi E. Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study. J. Nutr. 2002, 132:303-306.
9. Zucker S.D., Horn P.S., Sherman K.E. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004, 40:827-835.
10. Liu X., Meng Q.H., Ye Y., Hildebrandt M., Gu J., Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis 2014.
11. Keshavan P., Schwemberger S.J., Smith D.L., Babcock G.F., Zucker S.D. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int. J. Cancer 2004, 112:433-445.
12. Rao P., Suzuki R., Mizobuchi S., Yamaguchi T., Sasaguri S. Bilirubin exhibits a novel anti-cancer effect on human adenocarcinoma. Biochem. Biophys. Res. Commun. 2006, 342:1279-1283.
13. Ollinger R., Kogler P., Troppmair J., Hermann M., Wurm M., Drasche A., et al. Bilirubin inhibits tumor cell growth via activation of ERK. Cell Cycle 2007, 6:3078-3085.
14. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J. Thorac. Oncol. 2007, 2:706-714.
15. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
16. Temme E.H., Zhang J., Schouten E.G., Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001, 12:887-894.
17. Frost-Pineda K., Liang Q., Liu J., Rimmer L., Jin Y., Feng S., et al. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob. Res. 2011, 13:182-193.
18. O'Malley S.S., Wu R., Mayne S.T., Jatlow P.I. Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease. Nicotine Tob. Res. 2014, 16:1145-1149.
19. Doll R., Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br. Med. J. 1976, 2:1525-1536.
20. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994, 309:901-911.
21. Ettinger D.S., Wood D.E., Akerley W., Bazhenova L.A., Borghaei H., Camidge D.R., et al. Non-small cell lung cancer, version 1. 2015. J. Natl. Compr. Canc. Netw. 2014, 12:1738-1761.
22. Janjigian Y.Y., McDonnell K., Kris M.G., Shen R., Sima C.S., Bach P.B., et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer 2010, 116:670-675.
23. Kawaguchi T., Takada M., Kubo A., Matsumura A., Fukai S., Tamura A., et al. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. J. Thorac. Oncol. 2010, 5:620-630.
24. Zucker S.D., Goessling W., Hoppin A.G. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J. Biol. Chem. 1999, 274:10852-10862.
25. Weisiger R.A., Ostrow J.D., Koehler R.K., Webster C.C., Mukerjee P., Pascolo L., et al. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J. Biol. Chem. 2001, 276:29953-29960.